远程工作对药店主导的补充管理计划中的生产率的影响
Angelica A Berni1, Sara M Panella2, Yamilia Suros1
1Clinical Pharmacy Enterprise, Baptist Health South Florida, Miami Lakes, FL, USA.
概括
远程工作显著提高了药房补充管理的生产力,药剂师每天处理的药物要求增加了18%. 这种远程工作模式显示出提高医疗保健机构劳动力灵活性和招聘的前景.
科学领域:
- 药房实践 在药房实践中
- 医疗保健服务研究 医疗服务研究
- 远程工作模型 远程工作模型
背景情况:
- 由于COVID-19大流行,医疗机构需要快速采用远程工作,包括远程工作.
- 远程工作对药房运营生产力的影响,特别是补充管理,需要进行彻底的评估,以告知疫情后的可持续性.
- 药房主导的补充管理计划对于药物坚持和患者护理连续性至关重要.
研究的目的:
- 评估远程工作对药剂师生产力的影响,在补充管理计划中.
- 确定在流行后维持远程工作的可行性和好处.
- 通过远程工作评估药物补充处理效率的变化.
主要方法:
- 一项前性队列研究,涉及7名药剂师,在远程和办公室工作之间交替工作.
- 通过比较每名药剂师处理的每日药物补充请求来衡量生产率.
- 从2023年4月至6月的电子健康记录中收集的数据,包括满足的请求和工作时间.
主要成果:
- 远程工作导致处理的每日药物补充请求增加了18% (89.2 vs 75.5请求/天,P < 0.0004).
- 药剂师在远程工作时在非补充任务上花费的时间更少,尽管总工作时间相似.
- 在研究期间,共处理了59,090个补充请求.
结论:
- 远程工作显著提高了药房补充管理中的生产力.
- 这些发现支持远程工作模式的可持续性,以提高劳动力灵活性和药房服务的招聘.
- 建议进行进一步的研究,以探索远程药房环境中的员工满意度和其他生产力影响因素.
相关概念视频
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
350
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
350
01:29Therapeutic Drug Monitoring: Affecting Factors
200
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
200
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
211
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
211
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
148
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
148
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
210
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
210
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
249
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
249